Search

PROCEPT BioRobotics Corp

Gesloten

SectorGezondheidszorg

22.86 5.54

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

21.01

Max

22.88

Belangrijke statistieken

By Trading Economics

Inkomsten

-27M

-58M

Verkoop

11M

94M

EPS

-0.47

Winstmarge

-61.905

Werknemers

888

EBITDA

5.1M

-24M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+6.54% upside

Dividenden

By Acuity

Volgende Winsten

3 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

197M

1.2B

Vorige openingsprijs

17.32

Vorige sluitingsprijs

22.86

Nieuwssentiment

By Acuity

50%

50%

135 / 340 Rangschikking in Healthcare

PROCEPT BioRobotics Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 aug 2026, 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

10 aug 2026, 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7 aug 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6 aug 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5 aug 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4 aug 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3 aug 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31 jul 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30 jul 2026, 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29 jul 2026, 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28 jul 2026, 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27 jul 2026, 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22 jul 2026, 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21 jul 2026, 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20 jul 2026, 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Peer Vergelijking

Prijswijziging

PROCEPT BioRobotics Corp Prognose

Koersdoel

By TipRanks

6.54% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 23.13 USD  6.54%

Hoogste 29 USD

Laagste 19 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor PROCEPT BioRobotics Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

11 ratings

3

Buy

7

Hold

1

Sell

Sentiment

By Acuity

135 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat